08.12.24 -- Balancing Sustainability With Patient Safety In Medical Device Design

Explore considerations for the series of characterizations necessary to ensure the efficacy of a packaging or device component and final drug delivery system.

Increased demand for protein delivery and the emergence of advanced modalities – including mRNA – are introducing new challenges to the development lifecycle, such as high-concentration formulations.

Examine how an innovative formulation approach helped a developer create a version of their drug that promotes treatment compliance within the geriatric population.

Two experts discuss the ways companies can address issues with low bioavailability and the benefits of enlisting an experienced drug development partner.

As we balance the time-to-market and risk for novel therapies, we must anticipate changing needs for combination device development, highlighting the technological paradigm shift.

Learn how a partner who is committed to ensuring the safety of medical devices by mitigating the risk of chemical interaction with drugs is crucial for navigating the regulatory pathway to approval.